Back
Addex Therapeutics Ltd. 10K Form
Buy
52
ADXN
Addex Therapeutics Ltd.
Last Price:
$8.89
Seasonality Move:
34.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ADXN News And Ratings
See the #1 stock for the next 7 days that we like better than ADXN
ADXN Financial Statistics
Sales & Book Value
| Annual Sales: | $465.6K |
|---|---|
| Cash Flow: | $-687.4K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.70 |
| Price / Book: | 1.46 |
Profitability
| EPS (TTM): | -8.43730 |
|---|---|
| Net Income (TTM): | $-7.3M |
| Gross Margin: | $0 |
| Return on Equity: | -73.84% |
| Return on Assets: | -64.6% |
Addex Therapeutics Ltd. Earnings Forecast
Key Addex Therapeutics Ltd. Financial Ratios
-
The Gross Profit Margin over the past 21 years for ADXN is 0.00%.
-
The Selling, General & Administrative Expenses for ADXN have been equal to 563.60% of Gross Profit Margin.
-
The Research & Development expenses have been 145.08% of Revenue.
-
The Net Earning history of ADXN is -1,197.29% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 14 years.
Addex Therapeutics Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ADXN |
| Website: | addextherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 2.01 |
| Quick Ratio: | 1.91 |
Price-to-Earnings
| Trailing P/E Ratio: | 1.55 |
|---|---|
| Forward P/E Ratio: | 0 |
ADXN Technical Analysis vs Fundamental Analysis
Buy
52
Addex Therapeutics Ltd. (ADXN)
is a Buy
Is Addex Therapeutics Ltd. a Buy or a Sell?
-
Addex Therapeutics Ltd. stock is rated a BuyThe current Addex Therapeutics Ltd. [ADXN] share price is $8.20. The Score for ADXN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.